US Dollar vs Yen

登録して、同じ考えを持つ投資家と議論するためのアクティブなフォーラムで相互作用するためのアクティブなフォーラムに参加してください。

ホーム
投資
株式
アメリカ
NASDAQ
Keros Therapeutics Inc (KROS)
Keros Therapeutics Inc (KROS) ニュース

Keros Therapeutics Inc (KROS)

11.65

0.62

(5.62%)

終了 7月8日 5:00AM

11.65

0.005

(0.04%)

取引時間後: 7:35AM

個人投資家向けのプロ仕様のツール。

プレミアム

Form 4 - Statement of changes in beneficial ownership of securities

Form 3 - Initial statement of beneficial ownership of securities

Form 8-K - Current report

Keros Therapeutics Appoints Anne Prener to its Board of Directors

LEXINGTON, Mass., June 25, 2026 (GLOBE NEWSWIRE) -- Keros Therapeutics, Inc. (“Keros” or the “Company”...

Form 4 - Statement of changes in beneficial ownership of securities

Form 144 - Report of proposed sale of securities

Form 4 - Statement of changes in beneficial ownership of securities

Form 4 - Statement of changes in beneficial ownership of securities

Form 4 - Statement of changes in beneficial ownership of securities

Form 4 - Statement of changes in beneficial ownership of securities

Form 4 - Statement of changes in beneficial ownership of securities

Form 4 - Statement of changes in beneficial ownership of securities

Form 144 - Report of proposed sale of securities

Form 144 - Report of proposed sale of securities

Form 144 - Report of proposed sale of securities

TheFinalCD

TheFinalCD 1年前

$KROS halts all dosing in the TROPOS Phase 2 clinical trial of cibotercept (KER-012) based on the ongoing safety review due to new observations of pericardial effusion adverse events

$KROS halts all dosing in the TROPOS Phase 2 clinical trial of cibotercept (KER-012) based on the ongoing safety review due to new observations of pericardial effusion adverse events— Bio Stocks™ (@BioStocks) January 15, 2025

$KROS the TROPOS trial is being terminated early. The Co continues to expect to present topline data from all treatment arms in this trial in Q2
$KROS the TROPOS trial is being terminated early. The Co continues to expect to present topline data from all treatment arms in this trial in Q2— Bio Stocks™ (@BioStocks) January 15, 2025

retireat40

retireat40 2年前

Wow. What a turd

retireat40

retireat40 2年前

Shocked this is still sub 18

Dennis14

Dennis14 2年前

Bought in at 18.00

Monksdream

Monksdream 2年前

KROS more upside possible

Monksdream

Monksdream 2年前

KROS new 52=week high

Keros Therapeutics

Tintina Mines (PK)

Us Treasury 2027 15 11

Frontier Asset Global Sm...

Flt Rte Nts 29/03/30

Ko Nts Car 05/04/2028

GoGold Resources (QX)

Revelation Biosciences

PHLX US AI Semiconductor

Delayed Upgrade Clock

顧客サポート: +44 (0) 203 8794 460 | support@advfn.com

ADVFNのサービスをご利用いただくには、利用規約

ADVFN

すでにアカウントをお持ちですか？サインイン

アカウントをお持ちでないですか？登録

登録することで、ADVFN の利用規約を読み、理解し、同意したこと、および私が個人投資家であることを確認します。